This study investigates the effects of different chemotherapy drugs on patients with germ cell tumors, which are a type of cancer that can occur in the ovaries, testicles, or other areas. The purpose is to compare carboplatin and cisplatin to determine which is more effective for patients with standard risk tumors. Germ cell tumors can be classified into different risk levels based on factors like their stage and location.
Participants in the study may undergo active surveillance, which means doctors will closely monitor them after tumor removal, or receive chemotherapy treatments with drugs like bleomycin, carboplatin, etoposide, or cisplatin. These drugs work by killing cancer cells, stopping them from dividing, or preventing them from spreading.
- Who can participate: Participants can be children or adults up to 49 years old. They must have low or standard risk germ cell tumors, such as stage I ovarian immature teratoma or malignant germ cell tumors. Specific age criteria apply for standard risk categories.
- Study details: Participants may receive active surveillance or chemotherapy involving drugs like bleomycin, carboplatin, etoposide, or cisplatin. Some may receive a placebo, which is an inactive substance that looks like the investigational medication but does not contain any medicine.
